on ABIVAX (EPA:ABVX)
JP Morgan Chase & Co. crosses the 5% threshold in ABIVAX
On April 13, 2026, ABIVAX announced that JP Morgan Chase & Co., through its subsidiaries, had crossed the 5% threshold of voting rights in the company, now holding 5.23% of the share capital and 5.07% of the voting rights. This acquisition was made through JP Morgan Securities LLC, JP Morgan Securities plc, and JP Morgan Chase Bank.
This increase in shareholding primarily results from the purchase of ABIVAX shares by way of assimilation, including custody contracts and share swaps. JP Morgan Securities LLC and JP Morgan Securities plc specified their holdings through various financial instruments, such as equity swaps and call options, with maturities ranging from 2026 to 2033.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news